298 related articles for article (PubMed ID: 17903636)
1. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies.
Sebastiani M; Giordano C; Nediani C; Travaglini C; Borchi E; Zani M; Feccia M; Mancini M; Petrozza V; Cossarizza A; Gallo P; Taylor RW; d'Amati G
J Am Coll Cardiol; 2007 Oct; 50(14):1362-9. PubMed ID: 17903636
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H; Kinugawa S; Matsushima S
Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
[TBL] [Abstract][Full Text] [Related]
3. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
Giordano C; D'Amati G
Pathologica; 2005 Dec; 97(6):361-8. PubMed ID: 16619977
[TBL] [Abstract][Full Text] [Related]
4. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts.
Hansson A; Hance N; Dufour E; Rantanen A; Hultenby K; Clayton DA; Wibom R; Larsson NG
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3136-41. PubMed ID: 14978272
[TBL] [Abstract][Full Text] [Related]
5. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
6. Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.
Fosslien E
Ann Clin Lab Sci; 2003; 33(4):371-95. PubMed ID: 14584751
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomal analysis of failing and nonfailing human hearts.
Steenman M; Chen YW; Le Cunff M; Lamirault G; Varró A; Hoffman E; Léger JJ
Physiol Genomics; 2003 Jan; 12(2):97-112. PubMed ID: 12429867
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
Lebrecht D; Kokkori A; Ketelsen UP; Setzer B; Walker UA
J Pathol; 2005 Dec; 207(4):436-44. PubMed ID: 16278810
[TBL] [Abstract][Full Text] [Related]
9. The profound effects of microcystin on cardiac antioxidant enzymes, mitochondrial function and cardiac toxicity in rat.
Qiu T; Xie P; Liu Y; Li G; Xiong Q; Hao L; Li H
Toxicology; 2009 Mar; 257(1-2):86-94. PubMed ID: 19135122
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases.
Filosto M; Tonin P; Vattemi G; Spagnolo M; Rizzuto N; Tomelleri G
Acta Neuropathol; 2002 Mar; 103(3):215-20. PubMed ID: 11907800
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and heart disease.
DiMauro S; Hirano M
Curr Opin Cardiol; 1998 May; 13(3):190-7. PubMed ID: 9649942
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy.
Lebrecht D; Setzer B; Ketelsen UP; Haberstroh J; Walker UA
Circulation; 2003 Nov; 108(19):2423-9. PubMed ID: 14568902
[TBL] [Abstract][Full Text] [Related]
13. The effect of training on the expression of mitochondrial biogenesis- and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects.
Adhihetty PJ; Taivassalo T; Haller RG; Walkinshaw DR; Hood DA
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E672-80. PubMed ID: 17551003
[TBL] [Abstract][Full Text] [Related]
14. Divergent mitochondrial biogenesis responses in human cardiomyopathy.
Ahuja P; Wanagat J; Wang Z; Wang Y; Liem DA; Ping P; Antoshechkin IA; Margulies KB; Maclellan WR
Circulation; 2013 May; 127(19):1957-67. PubMed ID: 23589024
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease.
Glyn-Jones S; Song S; Black MA; Phillips AR; Choong SY; Cooper GJ
Physiol Genomics; 2007 Feb; 28(3):284-93. PubMed ID: 17062650
[TBL] [Abstract][Full Text] [Related]
16. Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray.
van der Westhuizen FH; van den Heuvel LP; Smeets R; Veltman JA; Pfundt R; van Kessel AG; Ursing BM; Smeitink JA
Neuropediatrics; 2003 Feb; 34(1):14-22. PubMed ID: 12690563
[TBL] [Abstract][Full Text] [Related]
17. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
Jung C; Martins AS; Niggli E; Shirokova N
Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
[TBL] [Abstract][Full Text] [Related]
18. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.
Wei YH; Wu SB; Ma YS; Lee HC
Chang Gung Med J; 2009; 32(2):113-32. PubMed ID: 19403001
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart.
Xu J; Nie HG; Zhang XD; Tian Y; Yu B
Mol Biol Rep; 2011 Aug; 38(6):4007-13. PubMed ID: 21127995
[TBL] [Abstract][Full Text] [Related]
20. Review: Metabolic cardiomyopathy and conduction system defects in children.
Gilbert-Barness E
Ann Clin Lab Sci; 2004; 34(1):15-34. PubMed ID: 15038665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
